182 related articles for article (PubMed ID: 8268855)
1. Inhibition of c-Ha-ras gene expression by hammerhead ribozymes containing a stable C(UUCG)G hairpin loop.
Koizumi M; Kamiya H; Ohtsuka E
Biol Pharm Bull; 1993 Sep; 16(9):879-83. PubMed ID: 8268855
[TBL] [Abstract][Full Text] [Related]
2. Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene.
Koizumi M; Kamiya H; Ohtsuka E
Gene; 1992 Aug; 117(2):179-84. PubMed ID: 1639266
[TBL] [Abstract][Full Text] [Related]
3. Design and anti-HIV-1 activity of hammerhead and hairpin ribozymes containing a stable loop.
Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
Nucleosides Nucleotides; 1998; 17(1-3):207-18. PubMed ID: 9708348
[TBL] [Abstract][Full Text] [Related]
4. Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR.
Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
Nucleic Acids Symp Ser; 1995; (34):125-6. PubMed ID: 8841584
[TBL] [Abstract][Full Text] [Related]
5. RNA hairpin loops repress protein synthesis more strongly than hammerhead ribozymes.
Drew HR; Lewy D; Conaty J; Rand KN; Hendry P; Lockett T
Eur J Biochem; 1999 Nov; 266(1):260-73. PubMed ID: 10542074
[TBL] [Abstract][Full Text] [Related]
6. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
Phylactou LA; Tsipouras P; Kilpatrick MW
Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
[TBL] [Abstract][Full Text] [Related]
7. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
Denman RB
Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic and antisense effects of a specific anti-Ki-ras ribozyme in vitro and in cell culture.
Giannini CD; Roth WK; Piiper A; Zeuzem S
Nucleic Acids Res; 1999 Jul; 27(13):2737-44. PubMed ID: 10373591
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake.
Bramlage B; Alefelder S; Marschall P; Eckstein F
Nucleic Acids Res; 1999 Aug; 27(15):3159-67. PubMed ID: 10454613
[TBL] [Abstract][Full Text] [Related]
10. Suppression of H-ras-mediated transformation in NIH3T3 cells by a ras ribozyme.
Funato T; Shitara T; Tone T; Jiao L; Kashani-Sabet M; Scanlon KJ
Biochem Pharmacol; 1994 Oct; 48(7):1471-5. PubMed ID: 7945447
[TBL] [Abstract][Full Text] [Related]
11. Reversal of the malignant phenotype by an anti-ras ribozyme.
Kashani-Sabet M; Funato T; Tone T; Jiao L; Wang W; Yoshida E; Kashfinn BI; Shitara T; Wu AM; Moreno JG
Antisense Res Dev; 1992; 2(1):3-15. PubMed ID: 1422085
[TBL] [Abstract][Full Text] [Related]
12. Suppression of BCR-ABL mRNA by various ribozymes in HeLa cells.
Kato Y; Kuwabara T; Toda H; Warashina M; Taira K
Nucleic Acids Symp Ser; 2000; (44):283-4. PubMed ID: 12903379
[TBL] [Abstract][Full Text] [Related]
13. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
Sioud M
Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
[TBL] [Abstract][Full Text] [Related]
14. Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes.
Sakamoto N; Wu CH; Wu GY
J Clin Invest; 1996 Dec; 98(12):2720-8. PubMed ID: 8981917
[TBL] [Abstract][Full Text] [Related]
15. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
Sun LQ; Wang L; Gerlach WL; Symonds G
Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
[TBL] [Abstract][Full Text] [Related]
16. Regulation of ribozyme cleavage activity by oligonucleotides.
Komatsu Y; Ohtsuka E
Methods Mol Biol; 2004; 252():165-77. PubMed ID: 15017048
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
[TBL] [Abstract][Full Text] [Related]
18. [Ribozyme targeted the point-mutation of activated oncogene inhibits its expression in vivo].
Liu G; Chen Y; Zhao X; Dong Y; Chen D
Yi Chuan Xue Bao; 1996; 23(6):477-85. PubMed ID: 9084224
[TBL] [Abstract][Full Text] [Related]
19. Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells.
Hübinger G; Schmid M; Linortner S; Manegold A; Bergmann L; Maurer U
Exp Hematol; 2001 Oct; 29(10):1226-35. PubMed ID: 11602325
[TBL] [Abstract][Full Text] [Related]
20. Modulation of c-fms proto-oncogene in an ovarian carcinoma cell line by a hammerhead ribozyme.
Yokoyama Y; Morishita S; Takahashi Y; Hashimoto M; Tamaya T
Br J Cancer; 1997; 76(8):977-82. PubMed ID: 9376277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
